Mode
Text Size
Log in / Sign up
N/A Completed N=279 Randomized Single-blind Treatment

Dismantling the Components and Dosing of CBT for Co-Occurring Disorders

CBT Decoupling · CBT Anxiety Reduction · CBT Combined
Source: ClinicalTrials.gov NCT02161211 ↗
Enrolled (actual)
279
Serious AEs
0.0%
Results posted
Feb 2023
Primary outcomePrimary: Number of Participants That Relapsed to Drinking at 4 Months — 30; 43; 35 Participants — p=.673

Summary

The purpose of this study is to establish a brief CBT intervention that can largely, if not fully eliminate the deleterious effect of common co-occurring anxiety disorders on alcohol use disorder treatment outcomes.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants That Relapsed to Drinking at 4 Months
30; 43; 35 .673
PRIMARY
Number of Drinking Days in 4 Months Post Treatment
8.44; 13.04; 11.34 .133
PRIMARY
Number of Standard Drinks Per Drinking Day
17.17; 17.72; 17.67 .982
SECONDARY
Number of Participants Who Met SCID-IV Criteria for Alcohol Dependence at 4 Months
13; 21; 16 .685
SECONDARY
Number of Participants Who Relapsed to Hazardous Drinking
27; 39; 34 .608

Eligibility Criteria

Inclusion Criteria

  • diagnostic and Statistical Manual IV diagnosis of panic disorder, generalized anxiety disorder, and/or social anxiety disorder within the past 30 days;
  • inpatient treatment at Lodging Plus primarily for alcohol (vs. other drug) dependence
  • alcohol use in the 30 days preceding the study
  • ability to provide informed consent
  • minimum of a sixth grade reading level (deemed necessary to complete study materials);
  • willingness to provide contact information to confirm study follow-up appointments
  • lives within proximity to the Twin Cities (e.g., within about an hour's drive) for the purpose attending follow-up visits

Exclusion Criteria

  • lifetime history of psychosis or mania by history
  • cognitive or physical impairment that precludes study participation
  • currently and seriously suicidal (i.e., plan and intent)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02161211). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search